4KZ-19813-76250
2 vaccinations
2 coded responses
23 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 925 / CA
- Registered
- 2021-04-27
- Relationship
- Self
- Race
- N/A
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-04-27
Registered in v-safe
-
2021-04-27
Dose 1 — Pfizer-BioNTech
- 2021-04-27
-
2021-04-28
Survey response — days 1–6 daily, dose 1MedDRA: Intermenstrual bleeding, Vaginal haemorrhage — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: SpottingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-29
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
- 2021-04-30
- 2021-05-01
-
2021-05-02
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-05-03
- 2021-05-04
- 2021-05-11
-
2021-05-18
Dose 2 — Pfizer-BioNTech
- 2021-05-18
-
2021-05-19
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-05-20
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-05-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-05-22
- 2021-05-23
-
2021-05-24
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness, NauseaAdult check-in
- 2021-05-25
- 2021-06-01
- 2021-06-08
- 2021-06-17
- 2021-06-22
- 2021-06-29
-
2021-11-16
Survey response — 6 months, dose 2MedDRA: Dyspnoea, Pyrexia — Feeling: Good · Be unable to work or attend schoolFree text: Had fever and difficulty breathing when exposed by 6 peopleMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-27 | Pfizer-BioNTech | |
| 2 | 2021-05-18 | Pfizer-BioNTech |
Free text
Release 8 — days 1–6 daily, dose 1
Systemic reaction (other): Spotting
Release 10 — 6 months, dose 2
Symptoms: Had fever and difficulty breathing when exposed by 6 people
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dyspnoea | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SRO | Intermenstrual bleeding | ✓ | ✓ | ○ |
| SRO | Vaginal haemorrhage | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release